Nearly 20% of cancer drugs defective in 4 African nations
DW.COM
'defective drugs'
SUMMARY

An alarming study reveals that nearly 20% of cancer drugs in four African countries—Ethiopia, Kenya, Malawi, and Cameroon—are defective. A US and pan-African research group tested around 200 cancer drug samples and found incorrect active ingredient levels in about 17% of them. This raises serious health concerns, as patients may not receive effective treatment.

The study also highlights ongoing issues with counterfeit and substandard medications across the continent. Researchers emphasize the need for stringent regulations and better testing capabilities to combat these problems. "If you can't test it, you can't regulate it," one researcher stated.

Advertisement
Scroll to continue reading
▶︎ Click here for more breaking news